"Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A general term for various neoplastic diseases of the lymphoid tissue.
| Descriptor ID |
D008223
|
| MeSH Number(s) |
C04.557.386 C15.604.515.569 C20.683.515.761
|
| Concept/Terms |
Lymphoma- Lymphoma
- Lymphomas
- Sarcoma, Germinoblastic
- Germinoblastic Sarcoma
- Germinoblastic Sarcomas
- Sarcomas, Germinoblastic
- Reticulolymphosarcoma
- Reticulolymphosarcomas
- Germinoblastoma
- Germinoblastomas
- Lymphoma, Malignant
- Lymphomas, Malignant
- Malignant Lymphoma
- Malignant Lymphomas
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma".
This graph shows the total number of publications written about "Lymphoma" by people in this website by year, and whether "Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 2 | 6 |
| 1997 | 1 | 0 | 1 |
| 1998 | 5 | 0 | 5 |
| 1999 | 5 | 3 | 8 |
| 2000 | 6 | 1 | 7 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 6 | 4 | 10 |
| 2004 | 5 | 3 | 8 |
| 2005 | 3 | 3 | 6 |
| 2006 | 2 | 3 | 5 |
| 2007 | 1 | 1 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 4 | 2 | 6 |
| 2010 | 11 | 0 | 11 |
| 2011 | 7 | 1 | 8 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 1 | 3 |
| 2014 | 3 | 0 | 3 |
| 2015 | 3 | 1 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 6 | 0 | 6 |
| 2018 | 2 | 2 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 3 | 0 | 3 |
| 2021 | 3 | 1 | 4 |
| 2022 | 5 | 0 | 5 |
| 2023 | 3 | 0 | 3 |
| 2024 | 0 | 2 | 2 |
| 2025 | 4 | 0 | 4 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma" by people in Profiles.
-
Longitudinal Ovarian Reserve in Female Adolescents/Young Adults With Lymphoma: A Report From Children's Oncology Group Study ALTE11C1. Pediatr Blood Cancer. 2026 Nov; 73(11):e70641.
-
Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas. Mol Cancer. 2026 Apr 20; 25(1).
-
Hematolymphoid neoplasms involving the breast: A single institution clinicopathologic study of 59 patients. Ann Hematol. 2026 Apr 10; 105(5).
-
Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma. Neuro Oncol. 2026 Feb 01; 28(2):371-382.
-
Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approach. Am J Clin Pathol. 2025 11 19; 164(5):650-693.
-
Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimics. Nat Commun. 2025 Sep 29; 16(1):8341.
-
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas. Clin Cancer Res. 2025 Apr 01; 31(7):1233-1242.
-
Undiagnosed lymphoma detected during routine histocompatibility crossmatch: 3 case reports. Am J Transplant. 2025 Jul; 25(7):1561-1567.
-
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults. Blood Adv. 2025 Jan 28; 9(2):280-290.
-
Incidental detection of non-melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series. J Cutan Pathol. 2024 Dec; 51(12):1000-1007.